Publishing research that challenges the status quo on LDL's role in atherosclerosis or low-fiber diets is difficult.

“i i know that that other colleagues of mine dave feldman in the lipid world you know i would imagine in the gi world it's the same and certainly in the in the cancer or longevity world if if you're trying to tell a story that ldl might not be the cause of atherosclerosis de novo or perhaps there's a little more nuance in the ketogenic and low fiber discussion around the gut microbiome you're going against the status quo and i would imagine that the journals don't always want that story in the journal”